WASHINGTON, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)NATIONAL ALLIANCE OF STATE AND TERRITORIAL AIDS DIRECTORSDBA NASTAD, founded in 1992, is a mid-sized nonprofit in the Health Care sector that reported $26.5M in total revenue in fiscal year 2022. Revenue surged 47% from the prior year, signaling strong growth momentum.
NASTAD'S MISSION IS TO ADVANCE THE HEALTH AND DIGNITY OF PEOPLE LIVING WITH AND IMPACTED BY HIV/AIDS, VIRAL HEPATITIS, AND INTERSECTING EPIDEMICS BY STRENGTHENING GOVERNMENTAL PUBLIC HEALTH AND LEVERAGING COMMUNITY PARTNERSHIPS.
SYNDEMIC APPROACHESPREVENTION: NASTAD'S HIV PREVENTION AND SURVEILLANCE ACTIVITIES ARE PRIMARILY FUNDED THROUGH A CDC COOPERATIVE AGREEMENT TO CONDUCT CAPACITY BUILDING/TECHNICAL ASSISTANCE (TA)...
SYNDEMIC APPROACHESPREVENTION: NASTAD'S HIV PREVENTION AND SURVEILLANCE ACTIVITIES ARE PRIMARILY FUNDED THROUGH A CDC COOPERATIVE AGREEMENT TO CONDUCT CAPACITY BUILDING/TECHNICAL ASSISTANCE (TA) ACTIVITIES AND COMMUNICATION IN SUPPORT OF STATE AND LOCAL HIV PREVENTION PROGRAMS FUNDED FOR PHASE 1 OF ENDING THE HIV EPIDEMIC (EHE) INITIATIVE. ADDITIONALLY, NASTAD HAS RECEIVED FUNDING FROM CDC THROUGH CSTLTS TO DEVELOPMENT A LEARNING COMMUNITY REGARDING HIV CLUSTER DETECTION AND RESPONSE. ON SEPTEMBER 30, 2022, NASTAD RECEIVED FUNDING FROM CDC DHP FOR SUPPLEMENTAL FUNDS TO EXPANDED ON NASTAD'S EHE PHASE I IMPLEMENTATION ACTIVITIES. ON SEPTEMBER 30, 2022, NASTAD WAS FUNDED THROUGH A FIVE YEAR SUBAWARD FROM EMORY UNIVERSITY FOR A CDC NATIONAL HIV SELF-TESTING PROJECT CALLED TOGETHER TAKE ME HOME. VIRAL HEPATITIS: THROUGH A COOPERATIVE AGREEMENT WITH FUNDING FROM THE CDC'S DIVISION OF VIRAL HEPATITIS (THROUGH THE CSTLTS FUNDING MECHANISM) NASTAD HAS A (VIRTUAL) TECHNICAL ASSISTANCE (TA) CENTER (HEPTAC) TO SUPPORT HEALTH DEPARTMENT HEPATITIS PROGRAMS WITH THE PREVENTION, SURVEILLANCE, AND LABORATORY ACTIVITIES. THE PROGRAM INCLUDES SUPPORTING HEALTH DEPARTMENT HEPATITIS PREVENTION AND SURVEILLANCE PROGRAMS WITH TAILORED TECHNICAL ASSISTANCE AND OTHER MODALITIES INCLUDING VIRTUAL LEARNING COMMUNITIES. ADDITIONALLY, NASTAD IS FUNDED FOR ANOTHER COOPERATIVE AGREEMENT WITH CDC'S DIVISION OF VIRAL HEPATITIS: NATIONAL VIRAL HEPATITIS EDUCATION, AWARENESS, AND CAPACITY BUILDING FOR COMMUNITIES AND PROVIDERS (HEPNET). FINALLY, NASTAD'S HEPATITIS PROGRAM ALSO INCLUDES PARTICIPATION AND LEADERSHIP IN THE NATIONAL VIRAL HEPATITIS ROUNDTABLE AND PROMOTION OF FEDERAL PROGRAMS THAT ADDRESS HEPATITIS A (HAV) AND HEPATITIS B (HBV) VACCINE FOR HIGH-RISK ADULTS, PREVENTION OF HCV, CHRONIC HBV AND HCV AND HIV HCV CO INFECTION. THIS PROGRAM IS SUPPORTED BY BOTH THE MEMBERSHIP AND CORPORATE DONORS.DRUG USER HEALTH: SINCE SEPTEMBER 30, 2022, NASTAD HAS BEEN IMPLEMENTING A COOPERATIVE WITH CDC'S DVH FOR STRENGTHENING SYRINGE SERVICES PROGRAMS (SSPS) THROUGH WHICH NASTAD PROVIDES DIRECT FUNDING TO SSPS THROUGHOUT THE U.S. NASTAD HAD A COOPERATIVE WITH CDC DIVISION OF VIRAL HEPATITIS (DVH) FOR THE NATIONAL HARM REDUCTION TECHNICAL ASSISTANCE CENTER THAT ENDED JULY 31, 2023. IN ADDITION, SUPPORTING THE PROVISION OF TA TO SYRINGE SERVICES PROGRAMS (SSPS) AND OTHER HARM REDUCTION PROVIDERS, IT INCLUDED A DEMONSTRATION PROJECT THROUGH WHICH NASTAD AWARDED FUNDS TO SUPPORT SSPS WITH PROVIDING ACCESS TO MEDICATION ASSESSMENT TREATMENT AND OTHER SERVICES. NASTAD ALSO HELD COOPERATIVE AGREEMENTS WITH CDC THROUGH CSTLTS FOCUSED ON EXPANDING SSP CAPACITY TO RESPOND TO COVID 19 AND FOR AN EXPANSION OF THE OF NATIONAL HARM REDUCTION TECHNICAL ASSISTANCE CENTER TO INCLUDE COORDINATION OF SAMHSA-FUNDED TA PROVIDERS WHICH ENDED NOVEMBER 15, 2023.
STRENGTHENING PUBLIC HEALTH SYSTEMS:HEALTH CARE ACCESS: NASTAD IS IN THE SECOND YEAR OF A FIVE-YEAR COOPERATIVE AGREEMENT WITH HEALTH RESOURCES AND SERVICES ADMINISTRATION (HRSA) TO PROVIDE TECHNICAL...
STRENGTHENING PUBLIC HEALTH SYSTEMS:HEALTH CARE ACCESS: NASTAD IS IN THE SECOND YEAR OF A FIVE-YEAR COOPERATIVE AGREEMENT WITH HEALTH RESOURCES AND SERVICES ADMINISTRATION (HRSA) TO PROVIDE TECHNICAL ASSISTANCE (TA) FOR AIDS DRUG ASSISTANCE PROGRAMS (ADAP) AND RYAN WHITE PART B PROGRAMS. PROGRAM ACTIVITIES INCLUDE A FOCUS ON ADAP CLINICAL QUALITY, AS WELL AS TA TO ADAPS ON VARIOUS ISSUES INCLUDING IMPLEMENTATION OF THE AFFORDABLE CARE ACT (ACA), INSURANCE PURCHASING, INTEGRATED PLANNING, FINANCIAL FORECASTING, IMPLEMENTING QUALITY MEASURES AND NEW DATA COLLECTION ACTIVITIES, DEVELOPING, AND DISSEMINATING VARIOUS MATERIALS, AND IMPLEMENTING AND MONITORING DRUG PRICING AGREEMENTS. NASTAD HAS AN ONGOING PROJECT SUPPORTED BY CORPORATE DONORS TO MONITOR AND ASSESS THE STATUS OF STATE ADAPS AUTHORIZED UNDER PART B OF THE RYAN WHITE PROGRAM. IN ADDITION TO PRODUCING THE NATIONAL ADAP MONITORING PROJECT ANNUAL REPORT, THE PROGRAM PROVIDES TA TO STATE ADAPS REGARDING VARIOUS PROGRAMMATIC AND FISCAL ISSUES. NASTAD ALSO CONVENES AND SUPPORTS THE WORK OF AN ADAP CRISIS TASK FORCE, MADE UP OF STATE AIDS DIRECTORS AND ADAP COORDINATORS WORKING ON BEHALF OF ALL STATE HIV/AIDS PROGRAMS TO IMPROVE THE FISCAL STATUS OF STATE ADAP PROGRAMS. THIS PROGRAM IS SUPPORTED BY NASTAD'S MEMBERSHIP. HEALTH SYSTEMS INTEGRATION: NASTAD HAS TWO COOPERATIVE AGREEMENTS WITH HEALTH RESOURCES AND SERVICES ADMINISTRATION (HRSA). ONE IS SERVICE AS THE SYSTEMS COORDINATION PROVIDER (SCP) FOR HRSA'S ENDING THE HIV EPIDEMIC (EHE) INITIATIVE. THE SECOND COOPERATIVE AGREEMENT FOR A SPECIAL PROJECTS OF NATIONAL SIGNIFICANCE (SPNS) INITIATIVE: BUILDING CAPACITY TO IMPROVE COLLECTING AND REPORTING VIRAL SUPPRESSION DATA TO THE MEDICAID ADULT CORE SET.
ORGANIZATIONAL EXCELLENCE: CBA: NASTAD HAS A COOPERATIVE AGREEMENT WITH CDC'S DIVISION OF HIV PREVENTION (DHP) TO PROVIDE TECHNICAL ASSISTANCE TO HEALTH DEPARTMENTS AND CDC-DIRECTLY FUNDED...
ORGANIZATIONAL EXCELLENCE: CBA: NASTAD HAS A COOPERATIVE AGREEMENT WITH CDC'S DIVISION OF HIV PREVENTION (DHP) TO PROVIDE TECHNICAL ASSISTANCE TO HEALTH DEPARTMENTS AND CDC-DIRECTLY FUNDED COMMUNITY-BASED ORGANIZATIONS (CBOS) ON INTEGRATED HIV PREVENTION STRATEGIES. NATIONAL HIV AND HEPATITIS TECHNICAL ASSISTANCE MEETING: NASTAD CONVENES A TECHNICAL ASSISTANCE MEETING EACH YEAR FOR HIV PREVENTION, CARE INCLUDING ADAP COORDINATORS, HEPATITIS, AND DRUG USER HEALTH STAFF. IT IS SUPPORTED THROUGH CORPORATE CONTRIBUTIONS SPECIFICALLY FOR THIS PURPOSE.ANNUAL MEETING: NASTAD CONVENES AN ANNUAL MEETING OF THE GENERAL MEMBERSHIP EACH SPRING, SUPPORTED BY THE MEMBERSHIP AND CORPORATE DONORS. THIS PROGRAM INCLUDES ALL ACTIVITIES IN SUPPORT OF THE ANNUAL MEETING THAT ARE NOT DIRECTLY SUPPORTED BY OTHER PROGRAMS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2022 | 2021 | Change | |
|---|---|---|---|
| Revenue | $26,523,136 | $18,000,771 | +0.5% |
| Expenses | $25,983,603 | $17,011,945 | +0.5% |
| Net Income | $539,533 | $988,826 | -0.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| STEPHEN LEE | EXECUTIVE DIRECTOR | 40.00 |
Officer
|
$220,275 | $44,968 | $265,243 |
| NATALIE CRAMER | DEPUTY EXECUTIVE DIRECTOR, PROGRAM | 40.00 |
Key Emp
|
$171,002 | $23,409 | $194,411 |
| VIRGINIE CAREY | DEPUTY EXECUTIVE DIRECTOR, OPERATIONS | 40.00 |
Key Emp
|
$171,182 | $11,387 | $182,569 |
| TIM HORN | DIRECTOR, MEDICATION ACCESS | 40.00 |
Highest
|
$130,552 | $32,435 | $162,987 |
| EMILY SCHREIBER | SR DIR, POLICY & LEGISLATIVE AFFAIRS | 40.00 |
Highest
|
$139,122 | $22,315 | $161,437 |
| AUNTRE HAMP | SR DIR, PUBLIC HEALTH SYSTEMS | 40.00 |
Highest
|
$144,240 | $16,192 | $160,432 |
| ISAIAH WEBSTER III | SR DIR, ORGANIZATIONAL EXCELLENCE | 40.00 |
Highest
|
$137,746 | $19,029 | $156,775 |
| BOATEMAA NTIRI REID | SR DIR SYNDEMIC APPROACHES | 40.00 |
Highest
|
$127,235 | $8,790 | $136,025 |
| DAVID KERN | CHAIR (FROM 6/2023) | 1.50 |
Officer
Director
|
$0 | $0 | $0 |
| CLOVER BARNES | CHAIR-ELECT (END 6/2023) | 1.50 |
Officer
Director
|
$0 | $0 | $0 |
| ELIZABETH CRUTSINGER-PERRY | IMMEDIATE PAST CHAIR | 1.50 |
Officer
Director
|
$0 | $0 | $0 |
| SARAH BRAUNSTEIN | VICE CHAIR (FROM 6/2023) | 1.50 |
Officer
Director
|
$0 | $0 | $0 |
| RICARDO FERNANDEZ | VICE CHAIR (END 5/2023) | 1.50 |
Officer
Director
|
$0 | $0 | $0 |
| DEBRA GUILBAULT | SECRETARY | 1.50 |
Officer
Director
|
$0 | $0 | $0 |
| JEREMY TURNER | TREASURER | 1.50 |
Officer
Director
|
$0 | $0 | $0 |
| VINCE AGUON | DIRECTOR (FROM 3/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| MELVERTA BENDER | DIRECTOR (END 5/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| KATHLEEN BRADY | DIRECTOR (FROM 6/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| LARISA BRUNER | DIRECTOR (FROM 6/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| SAMUEL BURGESS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JACQUELYN CLYMORE | DIRECTOR (END 5/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| ANDY DILLEHAY | DIRECTOR (FROM 6/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| TOM DUNN | DIRECTOR (FROM 6/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| JAMILA EALEY | DIRECTOR (END 2/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| DAWN FUKUDA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ANTHONY HANNAH | DIRECTOR (FROM 6/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| MARIA JACKSON | DIRECTOR (FROM 6/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| CHRISTINE JONES | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KATHRYN MACOMBER | DIRECTOR (END 5/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| ALI MANSARAY | DIRECTOR (END 5/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| RANDY MAYER | DIRECTOR (END 5/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| FELENCIA MCGEE | DIRECTOR (FROM 6/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| VONTRESE MCGHEE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MARLENE MCNEESE | DIRECTOR (END 5/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| LORLETTE MOIR | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ANDREA PEREZ | DIRECTOR (FROM 6/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| THADDEUS PHAM | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MARISA RAMOS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SCOTT STOKES | DIRECTOR (FROM 6/23) | 1.00 |
Director
|
$0 | $0 | $0 |
| KIMBERLY TRUSS | DIRECTOR (FROM 6/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | No data | No data | No data | No data |
| 2023 | $26,523,136 | $25,983,603 | $13,162,788 | $539,533 |
| 2022 | $18,000,771 | $17,011,945 | $12,367,221 | $988,826 |
| 2021 | $12,449,778 | $11,208,549 | $9,712,969 | $1,241,229 |
| 2020 | $9,262,445 | $8,752,930 | $6,990,379 | $509,515 |
| 2019 | $13,405,364 | $13,073,457 | $7,125,193 | $331,907 |
| 2018 | $13,795,987 | $14,266,038 | $3,185,839 | $-470,051 |
Compare NATIONAL ALLIANCE OF STATE AND TERRITORIAL AIDS DIRECTORSDBA NASTAD with other nonprofits in District of Columbia and across the country.